{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:16:32Z","timestamp":1789265792284,"version":"build-2803163510"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Incannex Healthcare Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Study Objectives<\/jats:title>\n                  <jats:p>Current treatments for obstructive sleep apnea (OSA) are ineffective or not tolerated in a proportion of patients. Other therapeutic options are needed and pharmaceuticals may provide an alternative. This randomized, double-blind, placebo-controlled, crossover study examined the effect of a combination of acetazolamide and dronabinol (IHL-42X) at low, medium, and high doses on OSA severity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Participants with OSA (apnea\u2013hypopnea index; AHI \u226515 events\/hour) received 1 week of IHL-42X at each of three doses and placebo, each separated by a 1-week washout. The change from baseline in AHI, oxygen desaturation index (ODI), Epworth sleepiness score (ESS), and mood (profile of mood states) on the final night of each treatment arm relative to the change from baseline to placebo were the major endpoints. Adverse events (AEs) were monitored throughout.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ten of 11 participants completed the final night of at least one treatment arm. IHL-42X demonstrated a greater reduction in AHI from baseline compared with placebo (low, \u221219.7\u2005\u00b1\u200527.1; medium, \u221217.5\u2005\u00b1\u200523.3; high, \u221216.4\u2005\u00b1\u200523.8 vs. placebo, \u22122.8\u2005\u00b1\u200521.0 events\/hour; all p\u2005&amp;lt;\u2005.05). The change from baseline in ODI3% was greater for the medium IHL-42X dose when compared with placebo (\u221215.4\u2005\u00b1\u200519.0 vs. placebo, \u22122.8\u2005\u00b1\u200521.0 events\/hour; p\u2005&amp;lt;\u2005.05) but not the low or high doses (low, \u221215.2\u2005\u00b1\u200524.8; high, \u22128.3\u2005\u00b1\u200513.2 events\/hour). IHL-42X did not change ESS or mood. No serious AEs occurred; however, 35 mild\u2013moderate possibly, probably, or treatment-related AEs occurred during IHL-42X dosing and 5 occurred during placebo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>One week of nightly IHL-42X at low, medium, and high doses was well tolerated, safe, and associated with significant reductions in OSA severity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sleep\/zsae276","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:06:39Z","timestamp":1732637199000},"source":"Crossref","is-referenced-by-count":7,"title":["A randomized dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnea"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-6079","authenticated-orcid":false,"given":"Jennifer","family":"Walsh","sequence":"first","affiliation":[{"name":"Centre for Sleep Science, School of Human Sciences, University of Western Australia , Perth, Western Australia,","place":["Australia"]},{"name":"Department of Pulmonary Physiology and Sleep Medicine, West Australian Sleep Disorders Research Institute, Sir Charles Gairdner Hospital , Perth, Western Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Rankin","sequence":"additional","affiliation":[{"name":"Centre for Sleep Science, School of Human Sciences, University of Western Australia , Perth, Western Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Centre for Sleep Science, School of Human Sciences, University of Western Australia , Perth, Western Australia,","place":["Australia"]},{"name":"Department of Pulmonary Physiology and Sleep Medicine, West Australian Sleep Disorders Research Institute, Sir Charles Gairdner Hospital , Perth, Western Australia,","place":["Australia"]},{"name":"Department of Respiratory Medicine, Joondalup Health Campus , Joondalup, Western Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T","family":"Naughton","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sleep Medicine Service, Alfred Health , Melbourne, Victoria,","place":["Australia"]},{"name":"Department of Medicine, School of Translational Medicine, Monash University , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teanau","family":"Roebuck","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sleep Medicine Service, Alfred Health , Melbourne, Victoria,","place":["Australia"]},{"name":"Department of Medicine, School of Translational Medicine, Monash University , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sleep Medicine Service, Alfred Health , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pattichis","sequence":"additional","affiliation":[{"name":"Epilepsy and Neuropharmacology Clinical Trials Unit, Alfred Brain, Alfred Health , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Smith","sequence":"additional","affiliation":[{"name":"Epilepsy and Neuropharmacology Clinical Trials Unit, Alfred Brain, Alfred Health , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Walsh","sequence":"additional","affiliation":[{"name":"Incannex Healthcare Limited , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bleackley","sequence":"additional","affiliation":[{"name":"Incannex Healthcare Limited , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Maddison","sequence":"additional","affiliation":[{"name":"Centre for Sleep Science, School of Human Sciences, University of Western Australia , Perth, Western Australia,","place":["Australia"]},{"name":"Department of Pulmonary Physiology and Sleep Medicine, West Australian Sleep Disorders Research Institute, Sir Charles Gairdner Hospital , Perth, Western Australia,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Epilepsy and Neuropharmacology Clinical Trials Unit, Alfred Brain, Alfred Health , Melbourne, Victoria,","place":["Australia"]},{"name":"Department of Neuroscience, School of Translational Research, Monash University , Melbourne, Victoria,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"issue":"6","key":"2025041104533277100_CIT0001","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.5664\/jcsm.9886","article-title":"Prevalence of common sleep disorders in a middle-aged community sample","volume":"18","author":"McArdle","year":"2022","journal-title":"J Clin Sleep Med."},{"issue":"11","key":"2025041104533277100_CIT0002","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1164\/rccm.201601-0099OC","article-title":"Upper-airway collapsibility and loop gain predict the response to oral appliance therapy in patients with obstructive sleep apnea","volume":"194","author":"Edwards","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"issue":"10","key":"2025041104533277100_CIT0003","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1164\/rccm.201808-1493OC","article-title":"The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. a randomized, placebo-controlled, double-blind crossover trial","volume":"199","author":"Taranto-Montemurro","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"2025041104533277100_CIT0004","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.smrv.2023.101809","article-title":"Pharmacotherapy for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Lee","year":"2023","journal-title":"Sleep Med Rev."},{"issue":"6","key":"2025041104533277100_CIT0005","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.chest.2020.06.078","article-title":"Acetazolamide for OSA and central sleep apnea: a comprehensive systematic review and meta-analysis","volume":"158","author":"Schmickl","year":"2020","journal-title":"Chest."},{"key":"2025041104533277100_CIT0006","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2013.00001","article-title":"Proof of concept trial of dronabinol in obstructive sleep apnea","volume":"4","author":"Prasad","year":"2013","journal-title":"Front Psychiatry."},{"issue":"9","key":"2025041104533277100_CIT0007","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsx112","article-title":"Effects of cannabinoid agonists and antagonists on sleep and breathing in sprague-dawley rats","volume":"40","author":"Calik","year":"2017","journal-title":"Sleep."},{"issue":"10","key":"2025041104533277100_CIT0008","doi-asserted-by":"publisher","first-page":"e111412","DOI":"10.1371\/journal.pone.0111412","article-title":"Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats","volume":"9","author":"Calik","year":"2014","journal-title":"PLoS One."},{"issue":"1","key":"2025041104533277100_CIT0009","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/ph15010100","article-title":"The safety of dronabinol and nabilone: a systematic review and meta-analysis of clinical trials","volume":"15","author":"Bajtel","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"2025041104533277100_CIT0010","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep."},{"key":"2025041104533277100_CIT0011","first-page":"150","article-title":"The development and use of the Stanford sleepiness scale (SSS)","volume":"9","author":"Hoddes","year":"1975","journal-title":"Psychophysiology."},{"key":"2025041104533277100_CIT0012","volume-title":"The Profile of Mood States 2nd Edition (POMS 2)","author":"Heuchert","year":"2012"},{"issue":"6","key":"2025041104533277100_CIT0013","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care."},{"key":"2025041104533277100_CIT0014","volume-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Version 2.5","author":"Berry","year":"2018"},{"issue":"1","key":"2025041104533277100_CIT0015","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsx184","article-title":"Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: effects of dronabinol in obstructive sleep apnea","volume":"41","author":"Carley","year":"2018","journal-title":"Sleep."},{"issue":"2","key":"2025041104533277100_CIT0016","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/thx.43.2.113","article-title":"Effects of acetazolamide in patients with the sleep apnoea syndrome","volume":"43","author":"Tojima","year":"1988","journal-title":"Thorax."},{"issue":"12","key":"2025041104533277100_CIT0017","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1164\/rccm.202109-2043OC","article-title":"A randomized controlled clinical trial exploring safety and tolerability of sulthiame in sleep apnea","volume":"205","author":"Hedner","year":"2022","journal-title":"Am J Respir Crit Care Med."},{"issue":"7","key":"2025041104533277100_CIT0018","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.5664\/jcsm.10528","article-title":"The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial","volume":"19","author":"Messineo","year":"2023","journal-title":"J Clin Sleep Med."},{"issue":"3","key":"2025041104533277100_CIT0019","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.chest.2023.09.022","article-title":"Modification of endotypic traits in OSA by the carbonic anhydrase inhibitor sulthiame","volume":"165","author":"Hoff","year":"2024","journal-title":"Chest."},{"issue":"5","key":"2025041104533277100_CIT0020","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","article-title":"Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea","volume":"590","author":"Edwards","year":"2012","journal-title":"J Physiol."},{"issue":"1","key":"2025041104533277100_CIT0021","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40463-016-0156-0","article-title":"Trends in CPAP adherence over twenty years of data collection: a flattened curve","volume":"45","author":"Rotenberg","year":"2016","journal-title":"J Otolaryngol Head Neck Surg."},{"issue":"1","key":"2025041104533277100_CIT0022","doi-asserted-by":"publisher","first-page":"e000557","DOI":"10.1136\/bmjresp-2020-000557","article-title":"Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence","volume":"7","author":"Schmickl","year":"2020","journal-title":"BMJ Open Respir Res."},{"issue":"11","key":"2025041104533277100_CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab149","article-title":"Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo","volume":"44","author":"Walsh","year":"2021","journal-title":"Sleep."},{"key":"2025041104533277100_CIT0024","doi-asserted-by":"publisher","first-page":"104433","DOI":"10.1016\/j.neubiorev.2021.11.004","article-title":"Are blood and oral fluid Delta(9)-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis","volume":"134","author":"McCartney","year":"2022","journal-title":"Neurosci Biobehav Rev."},{"issue":"12","key":"2025041104533277100_CIT0025","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/thoraxjnl-2020-214544","article-title":"Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysis","volume":"75","author":"Roeder","year":"2020","journal-title":"Thorax."},{"issue":"12","key":"2025041104533277100_CIT0026","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/jama.2020.14265","article-title":"Effect of multilevel upper airway surgery vs medical management on the apnea-hypopnea index and patient-reported daytime sleepiness among patients with moderate or severe obstructive sleep apnea: the SAMS randomized clinical trial","volume":"324","author":"MacKay","year":"2020","journal-title":"JAMA."}],"container-title":["SLEEP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsae276\/60818310\/zsae276.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/48\/4\/zsae276\/60818310\/zsae276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/48\/4\/zsae276\/60818310\/zsae276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:53:47Z","timestamp":1744347227000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsae276\/7908945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,26]]},"published-print":{"date-parts":[[2025,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsae276","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,11,26]]},"article-number":"zsae276"}}